Vistagen Therapeutics Inc

The current institutional shareholding score of Vistagen Therapeutics Inc is 3.00, ranking 193 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 37.96%, representing a quarter-over-quarter decrease of 34.37%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.74% of shares outstanding, with 0.65% increase in holdings.